NovoCure (NVCR) Launches 12.5M Common Stock IPO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/3/2026
- Wall Street ends lower as Middle East tensions escalate
- Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours
- Broadcom's sales and AI chip forecast comes in below expectations, shares tumble
- SpaceX sets IPO price at $135 ahead of roadshow in break with Wall Street norms
- Oil gains as Middle East hostilities flare
- Morgan Stanley lifts MU and SNDK targets, sees 2-3 years of tight memory supply
- Navitas showcases 800V power delivery board at NVIDIA MGX ecosystem event
- Inotiv files for bankruptcy with $65 million financing commitment
- Alphabet plans $80 billion equity raise to fund AI infrastructure expansion, Berkshire Hathaway to invest $10 billion
- Alphabet plans $80 billion raise for AI, backed by Buffett’s Berkshire
- After-Hours Stock Movers: AVGO, CRWD, FIVE, AI, TLYS, NTSK,
- After-Hours Stock Movers: PANW, CRWD, ZS, GTLB, ULTA
- After-Hours Stock Movers: HPE, CRDO, FULC, ABVX, MCHP
- After-Hours Stock Movers: DELL, MDB, AEO, NTAP, GAP, S, ADSK
- After-Hours Stock Movers: CRM, MRVL, SNOW, HPQ, DDOG, MDB, P, SNPS, BRZE, NCNO
NovoCure Limited (Nasdaq: NVCR) to Ring The Nasdaq Stock Market Opening Bell in Celebration of IPO
October 2, 2015 6:00 AM EDTADVISORY, Oct. 02, 2015 (GLOBE NEWSWIRE) --
What:Â
NovoCure Limited (Nasdaq: NVCR), a commercial stage oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, will visit the Nasdaq MarketSite in Times Square to celebrate its initial public offering (IPO).
In honor of the occasion, Asaf Danziger, Chief Executive Officer and Bill Doyle, Executive Chairman will ring the Opening Bell.Â
Where:
Nasdaq MarketSite 4 Times Square 43rd & Broadway Broadcast Studio
When:
Friday, October 2, 2015 9:15 a.m. to 9:30 a.m. ETÂ Â Â Â Â Â Â
NovoCure... More
NovoCure Limited (Nasdaq: NVCR) to Ring The Nasdaq Stock Market Opening Bell in Celebration of IPO
October 2, 2015 6:00 AM EDTADVISORY, Oct. 02, 2015 (GLOBE NEWSWIRE) --
What:Â
NovoCure Limited (Nasdaq: NVCR), a commercial stage oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, will visit the Nasdaq MarketSite in Times Square to celebrate its initial public offering (IPO).
In honor of the occasion, Asaf Danziger, Chief Executive Officer and Bill Doyle, Executive Chairman will ring the Opening Bell.Â
Where:
Nasdaq MarketSite 4 Times Square 43rd & Broadway Broadcast Studio
When:
Friday, October 2, 2015 9:15 a.m. to 9:30 a.m. ETÂ Â Â Â Â Â Â
NovoCure... More
NovoCure Limited Announces Launch of Initial Public Offering
October 1, 2015 9:07 PM EDTST. HELIER, Jersey--(BUSINESS WIRE)-- NovoCure Limited, a commercial stage oncology company pioneering a novel therapy for solid tumors, announced today the launch of its initial public offering of 12,500,000 shares of its common stock, including 7,500,000 shares to be sold by NovoCure Limited and 5,000,000 shares to be sold by selling shareholders. The initial public offer is currently expected to be between $26 and $29 per share. The underwriters for the offering will also have a 30-day option to purchase up to an additional 1,875,000 ordinary shares from the selling shareholders. NovoCure Limited has applied to list its common stock on the NASDAQ... More
